Navigation Links
Study Confirms Soy Isoflavones Reduce Menopausal Hot Flashes
Date:4/4/2012

DECATUR, Ill., April 4, 2012 /PRNewswire/ -- Archer Daniels Midland Company (NYSE: ADM) is pleased to share the results of a new meta-analysis on the effects of soy isoflavones in the alleviation of menopausal hot flashes. The analysis, which was published March 19 by Menopause: The Journal of The North American Menopause Society, found clear and consistent evidence that soy isoflavone supplements, like NovaSoy brand soy isoflavones, are significantly more effective than placebo in reducing the frequency and severity of hot flashes.

"The key finding in this study is that when you limit the analysis to isoflavone supplements derived from soy or those with profiles identical to soy, there is a very consistent effect on hot flash relief," said Mindy S. Kurzer, Ph.D, professor of nutrition at the University of Minnesota, hormone expert and contributing author to the study. "Almost all studies in the meta-analysis show a consistent reduction in hot flash frequency and severity."

The meta-analysis – which is the largest and most comprehensive conducted to date – revealed that ingestion of soy isoflavones for six weeks to 12 months significantly reduced the frequency of hot flashes by more than 20 percent compared with placebo. Soy isoflavones also significantly reduced hot flash severity by more than 26 percent compared with placebo. The analysis found that the decrease in hot flash frequency in longer duration trials (more than 12 weeks) was approximately threefold greater than the decrease in shorter-duration trials.

"For women who are bothered by hot flashes, any reduction in frequency or severity may be welcome – especially if it can be achieved without side effects," said Melissa K. Melby, Ph.D (University of Delaware), hot flash expert and contributing author to the study. "Soy isoflavones appear to be a good first approach to alleviating hot flashes. Since there is often a large placebo effect, women taking supplements with the right soy isoflavone profile will likely see at least a 50 percent reduction compared to doing nothing."

Though many different isoflavones exist in nature, the three found in soy are genistein, daidzein and glycitein. According to the authors of the study, isoflavone supplements providing higher amounts of genistein were approximately 50 to 200 percent more potent at reducing hot flash frequency than isoflavone supplements containing lower amounts of genistein.

"Supplements providing a total of 50 mg of total isoflavones will be effective as long as they also provide at least 19 milligrams of genistein," said Mark Messina, Ph.D, soy expert, industry consultant and contributing author to the study.

"We are pleased that such a thorough evaluation of the most well-conducted studies showed that soy isoflavones are highly effective for the alleviation of hot flashes," said Steve O'Brien, product manager of Natural Health and Nutrition at ADM. "To maximize relief, ADM's NovaSoy brand soy isoflavones reflect the same profile of isoflavones naturally present in soy, including higher amounts of genistein."

"Hot flashes are one of the most common symptoms of menopause," added Messina. "For women with moderate-to-severe hot flashes who are seeking relief from symptoms, the reduction in the number and severity of hot flashes observed in our analysis in response to soy isoflavones will likely result in a significant improvement in quality of life."

A meta-analysis is a statistical analysis of a large number of studies for the purpose of integrating the findings. Of the 17 studies included in the meta-analyses, 13 trials (including 1,196 women) evaluated hot flash frequency, and nine trials (including 988 women) evaluated hot flash severity.

The analysis was conducted by Kyoko Taku, Ph.D, MD (National Institutes of Health, Japan); Melby; Fredi Kronenberg, Ph.D (Stanford University); Kurzer; and Messina. The complete article will be published in the July issue of Menopause.

NovaSoy brand products are available in drug, grocery, and health and nutrition stores and easily identifiable by the distinctive leaf logo. For more information about NovaSoy, including a list of products that contain NovaSoy, please visit www.NovaSoy.com.

About ADM

For more than a century, the people of Archer Daniels Midland Company (NYSE: ADM) have transformed crops into products that serve vital needs. Today, 30,000 ADM employees around the globe convert oilseeds, corn, wheat and cocoa into products for food, animal feed, chemical and energy uses. With more than 265 processing plants, 400 crop procurement facilities, and the world's premier crop transportation network, ADM helps connect the harvest to the home in more than 160 countries. For more information about ADM and its products, visit www.adm.com.

Archer Daniels Midland Company

Media Relations
Jessie McKinney
media@adm.com
217-424-5413

To schedule an interview with one of the research authors, contact:

Kristen Fraser
kfraser@stephanbrady.com
608-241-4141 ext. 229


'/>"/>
SOURCE Archer Daniels Midland Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)...   Acsis , a leading provider of supply ... research and advisory firm IDC has named it a ... Pharmaceutical Track and Trace Software 2016 Vendor Assessment (doc ... of the capabilities and business strategies of 10 vendors ... Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... 27, 2016  Hologic, Inc. (Nasdaq: ... for the fiscal second quarter ended March 26, ... $0.24 increased 41.2%, and non-GAAP diluted EPS of ... 5.8% on a reported basis, and 6.3% on ... posted another good quarter, highlighted by 14.6% growth ...
(Date:4/27/2016)... Italy , April 27, 2016 ... linear accelerator (MR-linac) platform will be the focal point ... meeting of the European Society for Radiotherapy & Oncology, ... Elekta,s MR-linac integrates a state-of-the-art radiotherapy system and a ... physician to clearly see the patient,s anatomy in real ...
Breaking Medicine Technology:
(Date:4/30/2016)... , ... April 30, 2016 , ... Orlando-based Maximized Living ... they go for gold in Rio. Under the care of Maximized Living doctors ... , In an unprecedented showing, Maximized Living is sending the largest contingent of elite ...
(Date:4/29/2016)... ... April 29, 2016 , ... Since launching its annual volunteer ... serving the footwear industry, has broken all previous participation records in its first ... 23 states during the months of April and May, the 2016 Footwear Cares ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... On Tuesday, ... hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, ... Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations ...
(Date:4/29/2016)... ... April 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) ... with sunny skies, a light breeze and temperatures in the 60s. Over 400 runners, ... Run and Walk and 1-mile walk were held to increase awareness about Lyme ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... that student team BioCellection won the $30,000 Perlman Grand Prize of the 2016 ... Gloeckner Undergraduate Award, the Michelson People’s Choice Award, and the Committee Award for ...
Breaking Medicine News(10 mins):